Empagliflozin proves beneficial in acute myocardial infarction: EMMY trial Dr. Kamal Kant Kohli11 Sept 2022 7:30 PM ISTAUSTRIA: Acute myocardial infarction (MI) patients who receive the SGLT2 inhibitor empagliflozin (Jardiance) early after the MI have improved markers...
Pegozafermin significantly reduces triglyceride levels in severe hypertriglyceridemia: ESC 2022 Medha Baranwal10 Sept 2022 11:00 AM ISTUSA: Phase II data from the ENTRIGUE trial showed that in patients with severe hypertriglyceridemia, the investogational FGF21 analog pegozafermin was...
Periodontitis tied to increased risk of dyslipidemia: Study Dr. Hiral patel10 Sept 2022 9:00 AM ISTIran: Periodontitis is associated with an increased risk of dyslipidemia, states an article published in the Journal of Diabetes & Metabolic...
Curcumin can be used as a novel approach to improving lipid profile: Study Dr. Shravani Dali9 Sept 2022 8:00 PM ISTCurcumin can be used as a novel approach in improving lipid profile according to a recent study published in the Nutrition, Metabolism and ...
Methamphetamine users at increased risk of cardiovascular disease, study says Medha Baranwal9 Sept 2022 8:00 PM ISTSan Francisco, CA: Methamphetamine users are at significantly increased risk of cardiovascular disease (CVD) and developing heart failure and...
SGLT2 inhibitors foundational therapy in all HF patients regardless of EF: Pooled analysis of DAPA-HF and DELIVER Dr. Kamal Kant Kohli9 Sept 2022 8:00 PM ISTPrevious studies have shown that the SGLT2 inhibitor dapagliflozin reduces cardiovascular mortality and morbidity in patients with diabetes, chronic...
Milvexian shows potential to reduce risk of ischaemic stroke Dr. Kamal Kant Kohli9 Sept 2022 7:15 PM ISTA phase 2 trial in patients with a prior ischaemic stroke or high-risk transient ischaemic attack (TIA) has indicated that milvexian should be further...
PPI users at increased risk of atherosclerotic cardiovascular diseases, finds study Medha Baranwal9 Sept 2022 10:00 AM ISTChina: Research published in the journal Atherosclerosis has linked protein pump inhibitors (PPIs) with an increased risk of atherosclerotic...
Preoperative SGLT2 inhibitors increase metabolic acidosis with euglycemia, study finds Aditi9 Sept 2022 9:30 AM ISTJapan: According to a retrospective matched cohort study, using sodium-glucose cotransporter 2 (SGLT2) inhibitor preoperatively is associated with...
Regular drinking increases burden of atrial fibrillation risk in young adults: JAMA Jacinthlyn Sylvia8 Sept 2022 8:00 PM ISTSouth Korea: Even in young individuals between the ages of 20 and 39, persistent moderate to heavy drinking and a larger cumulative alcohol...
Angiotensin-converting enzyme inhibitor decreases cerebral small vessel disease risk: AHA Jacinthlyn Sylvia8 Sept 2022 8:00 PM ISTUSA: A new study conducted by Eric D. Goldstein and the team showed that angiotensin-converting enzyme inhibitor was most consistently linked to...
PCI has no additional benefit over optimal medical therapy in ischemic cardiomyopathy: NEJM Medha Baranwal8 Sept 2022 11:30 AM ISTUK: Coronary revascularization with PCI did not provide any additional benefit among patients with severe ischemic left ventricular systolic...
